The metabolic syndrome and related characteristics in major depression: Inpatients and outpatients compared metabolic differences across treatment settings

General Hospital Psychiatry

Volumn 36, Issue 5, 2014, Pages 509-515

  Luppino, Floriana S ^a   Bouvy, Paul F ^b   Giltay, Erik J ^a   Penninx, Brenda W J H ^a,c,d   Zitman, Frans G ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Inpatients; Major depressive disorder; Metabolic characteristics; Metabolic syndrome; Outpatients

Indexed keywords

ANTIDEPRESSANT AGENT; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MIRTAZAPINE; NEUROLEPTIC AGENT; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRIACYLGLYCEROL; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; AGED; ANALYSIS OF COVARIANCE; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ASSESSMENT; COHORT ANALYSIS; CONTROLLED STUDY; DEPRESSION; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; DRUG USE; FEMALE; HOSPITAL CARE; HOSPITAL PATIENT; HUMAN; LIPID BLOOD LEVEL; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL HOSPITAL; METABOLIC SYNDROME X; METABOLISM; OUTPATIENT; OUTPATIENT CARE; PREVALENCE; PRIMARY MEDICAL CARE; REGRESSION ANALYSIS; SECONDARY HEALTH CARE; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE; WAIST HIP RATIO; AGE; DISEASE ASSOCIATION; GENDER; GLUCOSE BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; ADOLESCENT; COMORBIDITY; COMPARATIVE STUDY; DEPRESSIVE DISORDER, MAJOR; MIDDLE AGED; NETHERLANDS; PATHOPHYSIOLOGY; PRIMARY HEALTH CARE; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTIDEPRESSIVE AGENTS; COMORBIDITY; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; INPATIENTS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NETHERLANDS; OUTPATIENTS; PRIMARY HEALTH CARE; SECONDARY CARE; YOUNG ADULT;

EID: 84906101253     PISSN: 01638343     EISSN: 18737714     Source Type: Journal    
DOI: 10.1016/j.genhosppsych.2014.05.018     Document Type: Article

References (63)

1. Bjorntorp P. Do stress reactions cause abdominal obesity and comorbidities?. Obes Rev 2001, 2(2):73-86.
2. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002, 106(25):3143-3421.
3. Grundy S.M., Cleeman J.I., Daniels S.R., Donato K.A., Eckel R.H., Franklin B.A., et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005, 112(17):2735-2752.
4. Lamon-Fava S., Wilson P.W., Schaefer E.J. Impact of body mass index on coronary heart disease risk factors in men and women. The Framingham Offspring Study. Arterioscler Thromb Vasc Biol 1996, 16(12):1509-1515.
5. Katzmarzyk P.T., Reeder B.A., Elliott S., Joffres M.R., Pahwa P., Raine K.D., et al. Body mass index and risk of cardiovascular disease, cancer and all-cause mortality. Can J Public Health 2012, 103(2):147-151.
6. WHO Obesity: preventing and managing the global epidemic. Report of a WHO Consultation (TRS 894) 2000, WHO, Geneva.
7. van Dijk S.B., Takken T., Prinsen E.C., Wittink H. Different anthropometric adiposity measures and their association with cardiovascular disease risk factors: a meta-analysis. Neth Heart J 2012, 20(5):208-218.
8. Duivis H.E., de Jonge P., Penninx B.W., Na B.Y., Cohen B.E., Whooley M.A. Depressive symptoms, health behaviors, and subsequent inflammation in patients with coronary heart disease: prospective findings from the heart and soul study. Am J Psychiatry 2011, 168(9):913-920.
9. Lindberg G., Larsson G., Setterlind S., Rastam L. Serum lipids and mood in working men and women in Sweden. J Epidemiol Community Health 1994, 48(4):360-363.
10. Luppino F.S., de Wit L.M., Bouvy P.F., Stijnen T., Cuijpers P., Penninx B.W., et al. Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Arch Gen Psychiatry 2010, 67(3):220-229.
11. van Reedt Dortland A.K., Giltay E.J., van Veen T., Zitman F.G., Penninx B.W. Metabolic syndrome abnormalities are associated with severity of anxiety and depression and with tricyclic antidepressant use. Acta Psychiatr Scand 2010, 122(1):30-39.
12. Heiskanen T.H., Niskanen L.K., Hintikka J.J., Koivumaa-Honkanen H.T., Honkalampi K.M., Haatainen K.M., et al. Metabolic syndrome and depression: a cross-sectional analysis. J Clin Psychiatry 2006, 67(9):1422-1427.
13. Kahl K.G., Greggersen W., Schweiger U., Cordes J., Balijepalli C., Losch C., et al. Prevalence of the metabolic syndrome in unipolar major depression. Eur Arch Psychiatry Clin Neurosci 2012, 262(4):313-320.
14. Koponen H., Jokelainen J., Keinanen-Kiukaanniemi S., Kumpusalo E., Vanhala M. Metabolic syndrome predisposes to depressive symptoms: a population-based 7-year follow-up study. J Clin Psychiatry 2008, 69(2):178-182.
15. Richter N., Juckel G., Assion H.J. Metabolic syndrome: a follow-up study of acute depressive inpatients. Eur Arch Psychiatry Clin Neurosci 2010, 260(1):41-49.
16. Skilton M.R., Moulin P., Terra J.L., Bonnet F. Associations between anxiety, depression, and the metabolic syndrome. Biol Psychiatry 2007, 62(11):1251-1257.
17. Mattoo S.K., Singh S.M. Prevalence of metabolic syndrome in psychiatric inpatients in a tertiary care centre in north India. Indian J Med Res 2010, 13146-13152.
18. Teixeira P.J., Rocha F.L. The prevalence of metabolic syndrome among psychiatric inpatients in Brazil. Rev Bras Psiquiatr 2007, 29(4):330-336.
19. Vancampfort D., Correll C.U., Wampers M., Sienaert P., Mitchell A.J., De Herdt A., et al. Metabolic syndrome and metabolic abnormalities in patients with major depressive disorder: a meta-analysis of prevalences and moderating variables. Psychol Med 2013, 1-12.
20. Koponen H., Jokelainen J., Keinanen-Kiukaanniemi S., Vanhala M. Depressive symptoms and 10-year risk for cardiovascular morbidity and mortality. World J Biol Psychiatry 2010, 11(6):834-839.
21. Seppala J., Vanhala M., Kautiainen H., Eriksson J., Kampman O., Mantyselka P., et al. Prevalence of metabolic syndrome in subjects with melancholic and non-melancholic depressive symptoms. A Finnish population-based study. J Affect Disord 2012, 136(3):543-549.
22. Vogelzangs N., Beekman A.T., Kritchevsky S.B., Newman A.B., Pahor M., Yaffe K., et al. Psychosocial risk factors and the metabolic syndrome in elderly persons: findings from the Health, Aging and Body Composition study. J Gerontol A Biol Sci Med Sci 2007, 62(5):563-569.
23. Penninx B.W., Beekman A.T., Smit J.H., Zitman F.G., Nolen W.A., Spinhoven P., et al. The Netherlands Study of Depression and Anxiety (NESDA): rationale, objectives and methods. Int J Methods Psychiatr Res 2008, 17(3):121-140.
24. Lyketsos C.G., Nestadt G., Cwi J., Heithoff K., Eaton W.W. The life-chart method to describe the course of psychopathology. Int J Methods Psychiatr Res 1994, 4:143-155.
25. World Health Organisation WHO Collaborating Centre for Drug Statistics Methodology. Anatomical Therapeutic Chemical (ATC) classification 2009, http://www.whocc.no/atc_ddd_index/, World Health Organisation.
26. Vogelzangs N., Suthers K., Ferrucci L., Simonsick E.M., Ble A., Schrager M., et al. Hypercortisolemic depression is associated with the metabolic syndrome in late-life. Psychoneuroendocrinology 2007, 32(2):151-159.
27. Preacher K.J., Hayes A.F. Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models. Behav Res Methods 2008, 40(3):879-891.
28. Zeugmann S., Quante A., Heuser I., Schwarzer R., Anghelescu I. Inflammatory biomarkers in 70 depressed inpatients with and without the metabolic syndrome. J Clin Psychiatry 2010, 71(8):1007-1016.
29. Paslakis G., Gilles M., Lederbogen F., Schilling C., Scharnholz B., Deuschle M. The effect of a 4-week treatment with reboxetine on metabolic parameters of depressed inpatients. Eur Arch Psychiatry Clin Neurosci 2011, 261(3):173-177.
30. Weber-Hamann B., Werner M., Hentschel F., Bindeballe N., Lederbogen F., Deuschle M., et al. Metabolic changes in elderly patients with major depression: evidence for increased accumulation of visceral fat at follow-up. Psychoneuroendocrinology 2006, 31(3):347-354.
31. Hummel J., Westphal S., Weber-Hamann B., Gilles M., Lederbogen F., Angermeier T., et al. Serum lipoproteins improve after successful pharmacologic antidepressant treatment: a randomized open-label prospective trial. J Clin Psychiatry 2011, 72(7):885-891.
32. Olusi S.O., Fido A.A. Serum lipid concentrations in patients with major depressive disorder. Biol Psychiatry 1996, 40(11):1128-1131.
33. Baghai T.C., Varallo-Bedarida G., Born C., Hafner S., Schule C., Eser D., et al. Major depressive disorder is associated with cardiovascular risk factors and low Omega-3 Index. J Clin Psychiatry 2011, 72(9):1242-1247.
34. Tedders S.H., Fokong K.D., McKenzie L.E., Wesley C., Yu L., Zhang J. Low cholesterol is associated with depression among US household population. J Affect Disord 2011, 135(1-3):115-121.
35. Eckel R.H., Grundy S.M., Zimmet P.Z. The metabolic syndrome. Lancet 2005, 365(9468):1415-1428.
36. Lenoir H., Lacombe J.M., Dufouil C., Ducimetiere P., Hanon O., Ritchie K., et al. Relationship between blood pressure and depression in the elderly. The Three-City Study. J Hypertens 2008, 26(9):1765-1772.
37. Licht C.M., de Geus E.J., Seldenrijk A., van Hout H.P., Zitman F.G., van Dyck R., et al. Depression is associated with decreased blood pressure, but antidepressant use increases the risk for hypertension. Hypertension 2009, 53(4):631-638.
38. McIntyre R.S., Park K.Y., Law C.W., Sultan F., Adams A., Lourenco M.T., et al. The association between conventional antidepressants and the metabolic syndrome: a review of the evidence and clinical implications. CNS Drugs 2010, 24(9):741-753.
39. Mezuk B., Eaton W.W., Albrecht S., Golden S.H. Depression and type 2 diabetes over the lifespan: a meta-analysis. Diabetes Care 2008, 31(12):2383-2390.
40. Paterniti S., Verdier-Taillefer M.H., Geneste C., Bisserbe J.C., Alperovitch A. Low blood pressure and risk of depression in the elderly. A prospective community-based study. Br J Psychiatry 2000, 176:464-467.
41. Reaven G.M. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988, 37(12):1595-1607.
42. Shinn E.H., Poston W.S., Kimball K.T., St Jeor S.T., Foreyt J.P. Blood pressure and symptoms of depression and anxiety: a prospective study. Am J Hypertens 2001, 14(7 Pt 1):660-664.
43. Strohle A. Physical activity, exercise, depression and anxiety disorders. J Neural Transm 2009, 116(6):777-784.
44. Landelijke stuurgroep multidisciplinaire richtlijnontwikkeling in de GGZ en het Trimbos-instituut. GGZ richtlijnen Depressie 2013.
45. Wakabayashi I. Smoking and lipid-related indices in patients with diabetes mellitus. Diabet Med 2014, 31(7):868-878.
46. Slagter S.N., van Vliet-Ostaptchouk J.V., Vonk J.M., Boezen H.M., Dullaart R.P., Kobold A.C., et al. Associations between smoking, components of metabolic syndrome and lipoprotein particle size. BMC Med 2013, 11195.
47. Roger V.L., Go A.S., Lloyd-Jones D.M., Adams R.J., Berry J.D., Brown T.M., et al. Heart disease and stroke statistics-2011 update: a report from the American Heart Association. Circulation 2011, 123(4):e18-e209.
48. Giltay E.J., Geleijnse J.M., Zitman F.G., Buijsse B., Kromhout D. Lifestyle and dietary correlates of dispositional optimism in men: the Zutphen Elderly Study. J Psychosom Res 2007, 63(5):483-490.
49. Kahn R., Buse J., Ferrannini E., Stern M. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2005, 28(9):2289-2304.
50. Luppino F.S., van Reedt Dortland A.K., Wardenaar K.J., Bouvy P.F., Giltay E.J., Zitman F.G., et al. Symptom dimensions of depression and anxiety and the metabolic syndrome. Psychosom Med 2011, 73(3):257-264.
51. Reaven G.M. The metabolic syndrome: requiescat in pace. Clin Chem 2005, 51(6):931-938.
52. Anagnostis P., Athyros V.G., Tziomalos K., Karagiannis A., Mikhailidis D.P. Clinical review: the pathogenetic role of cortisol in the metabolic syndrome: a hypothesis. J Clin Endocrinol Metab 2009, 94(8):2692-2701.
53. Park S.B., Blumenthal J.A., Lee S.Y., Georgiades A. Association of cortisol and the metabolic syndrome in Korean men and women. J Korean Med Sci 2011, 26(7):914-918.
54. Arnaldi G., Scandali V.M., Trementino L., Cardinaletti M., Appolloni G., Boscaro M. Pathophysiology of dyslipidemia in Cushing's syndrome. Neuroendocrinology 2010, 92:186-190. [Suppl].
55. Bremmer M.A., Beekman A.T., Deeg D.J., Penninx B.W., Dik M.G., Hack C.E., et al. Inflammatory markers in late-life depression: results from a population-based study. J Affect Disord 2008, 106(3):249-255.
56. Shoelson S.E., Herrero L., Naaz A. Obesity, inflammation, and insulin resistance. Gastroenterology 2007, 132(6):2169-2180.
57. Vaccarino V., Johnson B.D., Sheps D.S., Reis S.E., Kelsey S.F., Bittner V., et al. Depression, inflammation, and incident cardiovascular disease in women with suspected coronary ischemia: the National Heart, Lung, and Blood Institute-sponsored WISE study. J Am Coll Cardiol 2007, 50(21):2044-2050.
58. Rosmond R. Role of stress in the pathogenesis of the metabolic syndrome. Psychoneuroendocrinology 2005, 30(1):1-10.
59. Stahl S.M. Blue genes and the monoamine hypothesis of depression. J Clin Psychiatry 2000, 61(2):77-78.
60. Fries E., Hesse J., Hellhammer J., Hellhammer D.H. A new view on hypocortisolism. Psychoneuroendocrinology 2005, 30(10):1010-1016.
61. Pinto Pereira S.M., Ki M., Power C. Sedentary behaviour and biomarkers for cardiovascular disease and diabetes in mid-life: the role of television-viewing and sitting at work. PLoS One 2012, 7(2):e31132.
62. Stamler J. Low risk-and the "No more than 50%" myth/dogma. Arch Intern Med 2007, 167(6):537-539.
63. Wang T.J., Gona P., Larson M.G., Tofler G.H., Levy D., Newton-Cheh C., et al. Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med 2006, 355(25):2631-2639.